For Elevance Health and other big insurers, 2024 devolved into something of an annus horribilis over the year’s final weeks.
Evolent Health faces volatility with missed targets and 2024 guidance cuts. Click here for a full investment analysis of EVH ...
Hosted on MSN29d
Elevance Health (NYSE:ELV) Posts Q4 Sales In Line With EstimatesThis quarter, Elevance Health grew its revenue by 6.6% year on year, and its $45.44 billion of revenue was in line with Wall Street’s estimates. Looking ahead, sell-side analysts expect revenue ...
Shares of major healthcare companies Humana (NYSE: NYSE:HUM), CVS Health (NYSE: NYSE:CVS), Elevance Health, and Cigna (NYSE:CI) fell sharply in Friday's trading session, following a broader industry ...
The justice department is examining how the insurer’s methods of recording patient diagnoses could result in excess payments to UnitedHealth’s Medicare Advantage plans, a privately run offshoot of the ...
Many industries, from ads, to music, to gambling, are betting big on the Super Bowl.
Medtronic expects pressure in surgical unit for fourth quarter, shares fall Medtronic on Tuesday missed Wall Street ... setback to health regulators and activists. January 23, 2025 Elevance ...
Over the past year, many Elevance Health, Inc. ( NYSE:ELV ) insiders sold a significant stake in the company which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results